Sputnik V vaccine 92% effective on COVID-19: Russia institute


PTI, Nov 11, 2020, 5:01 PM IST

Hyderabad: SputnikV vaccine for COVID-19, being developed by Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology, has demonstrated an efficacy rate of 92 per cent.

The confirmation is based on the first interim data from the largest randomised, placebo-controlled Phase-III clinical trials in Russia involving 40,000 volunteers, a press release from Gamaleya and the Russian Direct Investment Fund (RDIF) said.

The trials evaluated the efficacy among over 16,000 volunteers who received the vaccine or placebo 21 days after the first injection. As a result of a statistical analysis of 20 confirmed cases of coronavirus, the case split between vaccinated individuals and those who received the placebo indicating that the Sputnik V vaccine had an efficacy rate of 92 per cent after the second dose, the release said.

In September 2020,Dr. Reddys and Russian Direct Investment Fund (RDIF), Russias sovereign wealth fund,entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine toDr.Reddys upon regulatory approval in India.

On August 11, 2020, the Sputnik V vaccine was registered by the Ministry of Health of Russia and became the worlds first registered vaccine against COVID-19 based on the human adenoviral vectors platform. Separately, in September the vaccine was first administered to a group of volunteers from the ‘red zones’ of Russian hospitals.

The observation of additional 10,000 vaccinated volunteers representing medics and other high-risk groups under the civil use of the vaccine out of clinical trials also confirmed the vaccines efficacy rate of over 90 per cent, the release added. As of November 11, as part of the clinical trials in Russias 29 medical centres, more than 20,000 volunteers were vaccinated with the first dose and over 16,000 volunteers with the first and the second dose of the vaccine.

In addition, as on the date, no unexpected adverse events were identified as part of the research. Some of those vaccinated had short-term minor adverse effects such as pain at the injection site, flu-like syndrome, including fever, weakness, fatigue, and headache, according to the release.

Alexander Gintsburg, director of Gamaleya Centre, said the publication of the interim results of the post-registration clinical trials that convincingly demonstrate Sputnik V vaccines efficacy gives way to mass vaccination in Russia against COVID-19 in the coming weeks.” Thanks to the production scale-up at new manufacturing sites, Sputnik V vaccine would soon be available for a wider population, he said. “This will break the current trend and lead to an eventual decrease in COVID-19 infection rates, first in Russia, then globally,” he said.

Pfizer Inc and BioNTech SE on Monday said their vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

FIR against Sanjay Raut’s brother for remarks against Shiv Sena’s woman leader

Kodagu murder case accused escapes from police in Hyderabad

Karnataka Maritime Board announces plans for Mangaluru Water Metro Project

Royal Enfield forays into electric bike segment; unveils first model under Flying Flea brand

US going to historically tight presidential election

Balasore tragedy result of composite negligence of railway officials: Orissa High Court

Actress Kasthuri stokes controversy by her remarks on Telugu-speaking people in TN

Related Articles More

Three Chinese astronauts enter space station after successful launch

What is AI superintelligence? Could it destroy humanity? And is it really almost here?

IIT-B develops method to maintain comfortable temperature inside homes in joint research

Scammers use fear and urgency to con people using ‘digital arrest’, online scams: Cyber advisory

ISRO to launch electric propelled satellite in Dec: Somanath

MUST WATCH

Gho Pooja in Deepavali Festival

Melukote Deepavali

Ganapathi Co-operative Society Ltd

Udayavani Chinnara Banna 2024

Annapoorna Aahar | Food Places In Mysore


Latest Additions

FIR against Sanjay Raut’s brother for remarks against Shiv Sena’s woman leader

Kodagu murder case accused escapes from police in Hyderabad

New software for fast-tracking project approvals: Karnataka Minister Patil

Karnataka Maritime Board announces plans for Mangaluru Water Metro Project

In-flight passengers can access WiFi services only when allowed, say new rules

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.